Press release
Generalized Anxiety Disorder (GAD) Patient Pool Analysis Market to Reach USD 1.42 Billion by 2034
Pune, India - December 2025 - The global Generalized Anxiety Disorder (GAD) Patient Pool Analysis Market, valued at USD 872.5 million in 2024, is projected to reach USD 1.42 billion by 2034, growing at a 5.0% CAGR (2025-2034), according to Exactitude Consultancy. Increasing prevalence of anxiety disorders, greater mental health awareness, and expanded clinical screening initiatives are driving demand for accurate epidemiological modeling of GAD populations.Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72126
Market Summary
The Generalized Anxiety Disorder Patient Pool Analysis Market is expanding as healthcare systems prioritize quantifying the rising burden of mental health conditions worldwide. GAD, characterized by excessive and persistent worry, affects individuals across all age groups and is strongly linked to stress, trauma, genetics, and comorbid psychiatric conditions. The global patient pool is growing rapidly due to urbanization, socioeconomic pressures, digital lifestyle stressors, and increased post-pandemic mental health complications.
More patients are being diagnosed as primary care physicians, psychiatrists, and digital mental health platforms integrate validated screening tools such as GAD-7 and GAD-2, significantly improving detection rates. Market growth is also supported by real-world data (RWD) collection, electronic health records (EHRs), insurance analytics, and large-scale mental health surveys that map incidence, prevalence, recurrence, and treatment-seeking patterns. North America leads in reported cases due to strong mental health reporting systems, while Asia-Pacific is the fastest-growing region, driven by rising awareness and reduced social stigma.
Key Takeaways
• 2024 Market Size: USD 872.5 Million
• 2034 Forecast: USD 1.42 Billion
• CAGR: 5.0% (2025-2034)
• Global anxiety prevalence rising due to lifestyle, social, and economic factors
• Digital mental health platforms expanding the diagnosed patient pool
• Asia-Pacific showing the fastest growth in newly reported GAD cases
Market Drivers
• Increasing global mental health awareness and reduced stigma
• Integration of GAD screening tools in primary care and telehealth
• Rising comorbidities such as depression, insomnia, and substance abuse
• Growing use of real-world epidemiology datasets for patient segmentation
• Higher prioritization of mental health in national healthcare policies
Segmentation Snapshot
By Data Source
• Hospital & Clinic Mental Health Records
• Insurance Claims Databases
• Telehealth & Digital Mental Health Platforms
• National Surveys & Epidemiology Studies
• Research Cohorts
By Patient Group
• Adults
• Adolescents
• Geriatric Population
• High-Risk Behavioral Groups
By End User
• Healthcare Providers
• Mental Health Researchers
• Pharmaceutical Companies
• Government Agencies
• CROs & Epidemiology Firms
By Region
• North America (Largest Patient Database)
• Europe
• Asia-Pacific (Fastest Growing)
• Latin America
• Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/72126/generalized-anxiety-disorder-patient-pool-analysis-market
Recent Developments
• Increasing adoption of GAD-7 digital self-screening tools.
• Telepsychiatry platforms collecting structured patient data for epidemiological mapping.
• Growing availability of AI-based mental health analytics for predicting disorder onset.
Expert Quote - Irfan Tamboli, Business Development Executive
"Rising stress levels and digital lifestyle pressures are significantly increasing the global GAD patient pool. Accurate epidemiological modeling is now essential to improve mental health resource planning and support therapy development."
Conclusion
The Generalized Anxiety Disorder Patient Pool Analysis Market will continue expanding through 2034 as public health systems, researchers, and pharmaceutical companies invest in detailed epidemiology mapping, digital screening tools, and global mental health surveillance programs.
This report is also available in the following languages : Japanese (全般性不安障害患者プール分析、市場), Korean (전반성 불안 장애 환자 풀 분석, 시장), Chinese (广泛性焦虑症患者群体分析,市场), French (Analyse du marché des patients atteints de trouble d'anxiété généralisée), German (Analyse des Patientenpools bei generalisierter Angststörung, Markt), and Italian (Analisi del pool di pazienti con disturbo d'ansia generalizzato, mercato), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/72126
Related Reports
Generalized Pustular Psoriasis (GPP) Market
https://exactitudeconsultancy.com/reports/71539/generalized-pustular-psoriasis-gpp-market
Generalized Anxiety Disorder Market
https://exactitudeconsultancy.com/reports/71905/generalized-anxiety-disorder-market
Partial Epilepsy Market
https://exactitudeconsultancy.com/reports/72067/partial-epilepsy-market
Generalized Myasthenia Gravis (gMG) Market
https://exactitudeconsultancy.com/reports/72089/generalized-myasthenia-gravis-gmg-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generalized Anxiety Disorder (GAD) Patient Pool Analysis Market to Reach USD 1.42 Billion by 2034 here
News-ID: 4304003 • Views: …
More Releases from Exactitude Consultancy
Bronchopulmonary Dysplasia (BPD) Patient Pool Analysis Market to Reach USD 593.4 …
Pune, India - December 2025 - The global Bronchopulmonary Dysplasia Patient Pool Analysis Market, valued at USD 331.2 million in 2024, is projected to reach USD 593.4 million by 2034, growing at a 6.1% CAGR (2025-2034), according to Exactitude Consultancy. Rising global preterm births, improved survival rates of extremely low birth weight infants, and enhanced neonatal intensive care capabilities are driving the demand for accurate BPD epidemiology and patient pool…
Partial Seizure Market to Reach USD 11.24 Billion by 2034 Driven by Rising Epile …
Pune, India - December 2025 - The global Partial Seizure Market, valued at USD 6.82 billion in 2024, is projected to reach USD 11.24 billion by 2034, growing at a 5.2% CAGR (2025-2034), according to Exactitude Consultancy. Increasing global epilepsy burden, development of new anti-seizure medications (ASMs), and expanded access to neurological diagnostics are fueling strong market growth.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72069
Market Summary
The Partial Seizure Market…
Partial Epilepsy Market to Reach USD 9.36 Billion by 2034
Pune, India - December 2025 - The global Partial Epilepsy Market, valued at USD 5.84 billion in 2024, is projected to reach USD 9.36 billion by 2034, growing at a 4.8% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of focal (partial) seizures, development of improved anti-epileptic drugs (AEDs), and advancements in neuroimaging and neuromodulation therapies are key growth drivers.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72067
Market Summary
The Partial…
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market to Reach USD 1 …
Pune, India - December 2025 - The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market, valued at USD 6.84 billion in 2024, is projected to reach USD 19.42 billion by 2034, growing at a robust 11.0% CAGR (2025-2034), according to Exactitude Consultancy. Rapid advancements in AAV-based gene therapies, antisense oligonucleotides (ASOs), RNA-targeting technologies, and improved diagnostic pathways are driving strong market momentum.
Download Full PDF Sample Copy of Market…
More Releases for Generalized
Key Trends Reshaping the Generalized Anxiety Disorder Market: Innovative Drug De …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Generalized Anxiety Disorder Market Size Growth Forecast: What to Expect by 2025?
The market encompassing generalized anxiety disorder has experienced consistent expansion over the preceding years, projected to increase its valuation from $7.76 billion in 2024 to $7.93 billion in the subsequent year, reflecting a compound annual growth rate…
Key Trends Influencing the Growth of the Generalized Anxiety Disorder Market in …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Generalized Anxiety Disorder Market Through 2025?
In recent years, there has been a consistent expansion in the market size for generalized anxiety disorder. The market, which is predicted to grow from $7.76 billion in 2024 to $8.01 billion in 2025, will experience…
Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder …
The Generalized Anxiety Disorder Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Generalized Anxiety Disorder Market Size and Projected Growth Rate?
The market size for generalized anxiety disorder has seen a stable growth in the past few years. The market is expected to…
Key Generalized Anxiety Disorder Market Trend for 2025-2034: Innovative Drug Dev …
"What Is the Future Outlook for the Generalized Anxiety Disorder Market's Size and Growth Rate?
The generalized anxiety disorder market will grow from $7.76 billion in 2024 to $8.01 billion in 2025, at a CAGR of 3.2%. Growth is driven by increased mental health awareness, pharmaceutical advances, the popularity of cognitive-behavioral therapy (CBT), and the stressful lifestyle changes of modern society.
The generalized anxiety disorder market is expected to reach $9.32 billion…
Generalized Anxiety Disorder Market Report and Forecast 2024-2032
Generalized Anxiety Disorder Market Outlook
The generalized anxiety disorder market size in the 7 major markets was valued at USD 1717.5 million in 2023, driven by the increasing advancements in psychotherapeutic as well as pharmacological treatment options for patients. The market is expected to grow at a CAGR of 5.4% during the forecast period of 2024-2032, with the values likely to rise from USD 1809.8 million in 2024 to USD 2751.1…
Generalized Anxiety Disorder Pipeline Insight Report 2023 (Updated)
(Albany, United States) As per DelveInsight's assessment, globally, the Generalized Anxiety Disorder Pipeline constitutes 10+ key companies continuously working towards developing 12+ Generalized Anxiety Disorder Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Generalized Anxiety Disorder Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Generalized…
